Longevity Acquisition Corporation announced that on October 21, 2020, it entered into an Agreement and Plan of Merger with 4D Pharma PLC and Dolphin Merger Sub Limited. Concurrent with the execution of the Merger Agreement and the receipt of the proceeds from the Note, Yukman Lau and Pai Liu resigned from their positions of director of the Company’s board of directors and director of the Board, respectively. On the same date, the Board appointed Alex Lyamport as director of the Board, Nicholas H. Adler as director of the Board and chairman of the compensation committee of the Board, and Jerry L. Hutter as director of the Board and chairman of the audit committee of the Board, to fill in the vacancies created by the Resignations. Lyamport has over 20 years of experience in origination, structuring and closing deals in media, technology, energy, consumer goods and agriculture in Central and Eastern Europe. He has been a Director and CFO of Navigation Acquisition Corp. since January 2018 and a Director at Navigator Principal Investors, LLC since 2012. Nicholas H. Adler is a practicing attorney in Nashville, Tennessee specializing in defense litigation, bankruptcy, foreclosure, and real estate matters. Hutter has over forty years of experience as an auditor, controller, CFO and management consultant for firms ranging from Fortune 500 companies to smaller private sector corporations and not-for-profit organizations. Since 2010, Hutter has served as director and Audit Committee Chairman of DJSP Enterprises Inc.